Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights

Phuoc T. Tran

Jarey H. Wang

Phuoc T. Tran, MD, PhD, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; Phuoc T. Tran, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Chad Tang, MD, Department of GU Radiation Oncology, MD Anderson Cancer Center, Houston, TX; and Ana P. Kiess, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD

Chad Tang

Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

Ana P. Kiess